Page updated 7/13/22
In February 2022, the U.S. Food and Drug Administration (FDA) announced investigation of consumer complaints of Cronobacter and Salmonella infections. All cases reportedly consumed powdered infant formula produced from the Abbott Nutrition facility in Sturgis, Michigan, and advised consumers against using specific logs of Similac, Alimentum, or EleCare powered infant formulas. Abbott soon issued a voluntary recall of powdered formulas manufactured in Sturgis. APFED is updating this page with resources and information as it becomes available.
Information and Resources from Abbott
Information and Resources from FDA
Information and Resources from HHS
Information and Resources from the White House
Information and Resources from Medical Societies and Nonprofit Organizations
Information and Resources from Manufacturers of Other Brands of Amino-acid Based Formula
What You Can Do
- Speak to your doctor before making any changes to your/your child’s diet or before using an alternative to regular brand of formula (see below).
- Do not dilute formula, such as by adding water, in attempt to make your existing supply last, nor attempt to make your own formula.
APFED is sharing information with patients and caregivers about the recall, and communicating questions and patient impacts to clinicians and researchers, the press, and to formula manufacturers. We are working collaboratively with research partners and other organizations to capture patient experience with accessing specialty ingredients and amino acid formulas during supply chain disruptions due to COVID and to this formula recall, and the impacts on disease management and health. The goal is a publication in the near future that documents barriers to access and can help inform future policies and frameworks to improve access to medical foods in the event of supply chain disruptions. We are also continuing our ongoing advocacy for passage of the Medical Nutrition Equity Act (see below for details).
Medical Nutrition Equity Act
The current formula shortage is a significant crisis, and we expect resolution in the near future. For those who are denied reimbursement by insurance for elemental formula, the lack of access will continue until there is legislation to facilitate that access. Please join us in calling on Congress to resolve this issue through enactment of the Medical Nutrition Equity Act. Visit nutritionequity.org to learn more and to take action!